Literature DB >> 2692091

Transtracheal oxygen delivery and patients with chronic obstructive pulmonary disease.

B S Bloom1, J M Daniel, M Wiseman, R S Knorr, R Cebul, W L Kissick.   

Abstract

A total of 43 severely ill COPD patients already on 24 h, or near 24 h, per day supplemental O2 were randomly assigned to transtracheal oxygen delivery (n = 22) or usual delivery of O2 by nasal cannula or face mask (n = 21). A few important changes were found in pulmonary function over time such as decreases of PEFR, FEF and MVV for both experimental and control groups, and FEV1% and FEV3% in experimental patients. At the same time, there was a significant decrease in both hematocrit and hemoglobin, and per cent shunting for the experimental group and a significant increase in per cent shunting in the control group. Physical, social and psychologic assessments showed significant improvement over time for experimental patients and declines for the control group. Lastly, medical costs were positively affected, as fewer days were spent in hospital post-study enrollment by experimental than control groups, and post-enrollment relative to pre-enrollment by experimental patients.

Entities:  

Mesh:

Year:  1989        PMID: 2692091     DOI: 10.1016/s0954-6111(89)80197-0

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  5 in total

1.  Indications of different oxygen sources.

Authors:  D Nolte
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  The role of oxygen saving devices in patients with chronic hypoxemia.

Authors:  J Moore-Gillon
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS.

Authors: 
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

4.  Long term continuous domiciliary oxygen therapy by transtracheal catheter.

Authors:  D A Walsh; J R Govan
Journal:  Thorax       Date:  1990-06       Impact factor: 9.139

5.  Portable liquid oxygen and exercise ability in severe respiratory disability.

Authors:  R M Leach; A C Davidson; S Chinn; C H Twort; I R Cameron; N T Bateman
Journal:  Thorax       Date:  1992-10       Impact factor: 9.139

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.